Reply to Kuek et al.: Optimism with Caution: Elexacaftor-Tezacaftor-Ivacaftor in Patients with Advanced Pulmonary Disease.
Pierre Regis BurgelJennifer Da SilvaJean-Louis PaillasseurClémence MartinPublished in: American journal of respiratory and critical care medicine (2021)
Keyphrases